OXALTIN 50 MG

Israel - English - Ministry of Health

Buy It Now

Active ingredient:
OXALIPLATIN 50 MG
Available from:
PERRIGO ISRAEL AGENCIES LTD
ATC code:
L01XA03
Pharmaceutical form:
POWDER FOR SOLUTION FOR INFUSION
Administration route:
I.V
Manufactured by:
ACTAVIS ITALY S.P.A
Therapeutic group:
OXALIPLATIN
Therapeutic indications:
Oxaliplatin in combination with 5-fluorouracil (5-FU) and folinic acid (FA) is indicated for:- Adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of primary tumour.-Treatment of metastatic colorectal cancer.
Authorization number:
150433345000
Authorization date:
2013-08-01

Similar products

Search alerts related to this product

Share this information